• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估基于大语言模型生成的肽作为发现针对临床超级细菌的有效加密抗菌肽的基础模板。

Evaluation of LLM-generated peptide as foundation template for discovery of effective encrypted AMPs against clinical superbugs.

作者信息

Zhao Lanlan, Wang Yihui, Jiang Jun, Pan Hongwei, Wang Lijuan, Ma Shutao, Zhang Lei

机构信息

Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine Shandong University, Jinan, China.

出版信息

Microbiol Spectr. 2025 Sep 2:e0150425. doi: 10.1128/spectrum.01504-25.

DOI:10.1128/spectrum.01504-25
PMID:40891852
Abstract

Novel antimicrobial agents are urgently needed to combat the antibiotic-resistance crisis, particularly in the face of multidrug-resistant (MDR) pathogens like carbapenem-resistant (CRAB) and methicillin-resistant (MRSA). In this study, we present an approach that combines generative large language model with sequence alignment to identify promising antimicrobial peptides. With this strategy, we rapidly identified five novel encrypted peptides based on a generated template, demonstrating significant antimicrobial activity against a broad spectrum of clinical MDR pathogens. Among them, PL-15 stood out as a potent, broad-spectrum AMP with comparable therapeutic efficacy to polymyxin B against CRAB infections . Mechanistic investigations revealed that PL-15 exerts its bactericidal effects by disrupting both the outer and cytoplasmic membranes, causing membrane depolarization, elevating intracellular reactive oxygen species (ROS) levels, and ultimately leading to rapid bacterial cell death. Additionally, PL-15 demonstrated remarkable antibiofilm activity, inhibiting biofilm formation and eradicating pre-existing biofilms, further reducing the risk of resistance development. This work highlights the potential of using generative model combined with sequence alignment to accelerate the discovery of novel analogs with enhanced properties.IMPORTANCEThe rise of multidrug-resistant pathogens, such as carbapenem-resistant and methicillin-resistant , poses a severe threat to public health, making the search for novel antimicrobial agents a critical priority. In this study, we present an innovative approach combining generative large language models and sequence alignment to identify promising antimicrobial peptides. This method allowed for the rapid discovery of five encrypted peptides with strong antimicrobial activity against a range of multidrug-resistant pathogens. Among them, PL-15 showed remarkable efficacy, comparable to polymyxin B, and exhibited potent antibiofilm properties, making it a strong candidate for further development. By providing a novel approach to discovering antimicrobial agents, this work presents a promising solution to the escalating crisis of antibiotic resistance.

摘要

迫切需要新型抗菌剂来应对抗生素耐药性危机,尤其是面对耐碳青霉烯类(CRAB)和耐甲氧西林(MRSA)等多重耐药(MDR)病原体时。在本研究中,我们提出了一种将生成式大语言模型与序列比对相结合的方法,以识别有前景的抗菌肽。通过这种策略,我们基于生成的模板快速鉴定出五种新型加密肽,它们对多种临床多重耐药病原体具有显著的抗菌活性。其中,PL-15脱颖而出,是一种强效的广谱抗菌肽,在治疗CRAB感染方面具有与多粘菌素B相当的疗效。机制研究表明,PL-15通过破坏外膜和细胞质膜发挥杀菌作用,导致膜去极化,提高细胞内活性氧(ROS)水平,最终导致细菌细胞迅速死亡。此外,PL-15表现出显著的抗生物膜活性,抑制生物膜形成并根除已形成的生物膜,进一步降低了耐药性产生的风险。这项工作突出了使用生成模型与序列比对相结合来加速发现具有增强特性的新型类似物的潜力。重要性耐碳青霉烯类和耐甲氧西林等多重耐药病原体的出现对公众健康构成了严重威胁,因此寻找新型抗菌剂成为一项至关重要的优先任务。在本研究中,我们提出了一种创新方法,将生成式大语言模型与序列比对相结合,以识别有前景的抗菌肽。该方法能够快速发现五种对多种多重耐药病原体具有强大抗菌活性的加密肽。其中,PL-15显示出与多粘菌素B相当的显著疗效,并表现出强大的抗生物膜特性,使其成为进一步开发的有力候选者。通过提供一种发现抗菌剂的新方法,这项工作为不断升级的抗生素耐药性危机提供了一个有前景的解决方案。

相似文献

1
Evaluation of LLM-generated peptide as foundation template for discovery of effective encrypted AMPs against clinical superbugs.评估基于大语言模型生成的肽作为发现针对临床超级细菌的有效加密抗菌肽的基础模板。
Microbiol Spectr. 2025 Sep 2:e0150425. doi: 10.1128/spectrum.01504-25.
2
AI-Driven Antimicrobial Peptide Discovery: Mining and Generation.人工智能驱动的抗菌肽发现:挖掘与生成
Acc Chem Res. 2025 Jun 17;58(12):1831-1846. doi: 10.1021/acs.accounts.0c00594. Epub 2025 Jun 3.
3
Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistant .克服噬菌体耐药性:序贯噬菌体-黏菌素疗法对碳青霉烯耐药菌的疗效
Microbiol Spectr. 2025 Aug 14:e0085525. doi: 10.1128/spectrum.00855-25.
4
The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K.源自两栖动物的肽TB_KKG6K的抗菌活性及治疗潜力
mSphere. 2025 Jun 25;10(6):e0101624. doi: 10.1128/msphere.01016-24. Epub 2025 May 19.
5
Anti-bacterial activity of dermcidin in human platelets: suppression of methicillin-resistant growth.人血小板中防御素的抗菌活性:抑制耐甲氧西林菌生长。
Microbiol Spectr. 2025 Jul;13(7):e0327324. doi: 10.1128/spectrum.03273-24. Epub 2025 May 27.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Deciphering the dynamics of methicillin-resistant Staphylococcus aureus biofilm formation: from molecular signaling to nanotherapeutic advances.解析耐甲氧西林金黄色葡萄球菌生物膜形成的动态过程:从分子信号到纳米治疗进展。
Cell Commun Signal. 2024 Mar 22;22(1):188. doi: 10.1186/s12964-024-01511-2.
8
The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant .抗菌肽Cec4对临床耐碳青霉烯类药物具有治疗潜力。
Microbiol Spectr. 2025 Jul;13(7):e0273824. doi: 10.1128/spectrum.02738-24. Epub 2025 May 16.
9
Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.黎巴嫩环境中耐碳青霉烯革兰氏阴性病原体的全国性监测。
Appl Environ Microbiol. 2025 Jul 23;91(7):e0193224. doi: 10.1128/aem.01932-24. Epub 2025 Jun 10.
10
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance.《2024年世界卫生组织细菌重点病原体清单》:一项用于指导针对抗菌药物耐药性的研究、开发及公共卫生策略的优先级排序研究。
Lancet Infect Dis. 2025 Apr 11. doi: 10.1016/S1473-3099(25)00118-5.